March 6, 2025 · Form 4 insider transaction
Imhoff John E bought 900,000 shares of GUIDED THERAPEUTICS INC, a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4.
On March 6, 2025, Mr. Imhoff converted 300 shares of Series D preferred stock into 900,000 shares of common stock. The Series D preferred stock had a stated value of $750 and $0.25 exercise price.